These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2941563

  • 1. Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer.
    Sanders LM, Kell BA, McRae GI, Whitehead GW.
    J Pharm Sci; 1986 Apr; 75(4):356-60. PubMed ID: 2941563
    [Abstract] [Full Text] [Related]

  • 2. Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres.
    Sanders LM, Kent JS, McRae GI, Vickery BH, Tice TR, Lewis DH.
    J Pharm Sci; 1984 Sep; 73(9):1294-7. PubMed ID: 6238157
    [Abstract] [Full Text] [Related]

  • 3. Nafarelin controlled release injectable: theoretical clinical plasma profiles from multiple dosing and from mixtures of microspheres containing 2 per cent, 4 per cent and 7 per cent nafarelin.
    Burns RA, Vitale K, Sanders LM.
    J Microencapsul; 1990 Sep; 7(3):397-413. PubMed ID: 2143531
    [Abstract] [Full Text] [Related]

  • 4. Disposition of nafarelin acetate, a potent agonist of luteinizing hormone-releasing hormone, in rats and rhesus monkeys.
    Chu NI, Chan RL, Hama KM, Chaplin MD.
    Drug Metab Dispos; 1985 Sep; 13(5):560-5. PubMed ID: 2865103
    [Abstract] [Full Text] [Related]

  • 5. Effect on corpus luteum function of luteal phase administration of a potent gonadotropin-releasing hormone analog (nafarelin).
    Schriock ED, Monroe SE, Martin MC, Henzl MR, Jaffe RB.
    Fertil Steril; 1985 Jun; 43(6):844-50. PubMed ID: 3158549
    [Abstract] [Full Text] [Related]

  • 6. In vivo characteristics of low molecular weight copoly (D,L-lactic acid) formulations with controlled release of LH-RH agonist.
    Asano M, Fukuzaki H, Yoshida M, Kumakura M, Mashimo T, Yuasa H, Imai K, Yamanaka H.
    Biomaterials; 1989 Oct; 10(8):569-73. PubMed ID: 2513891
    [Abstract] [Full Text] [Related]

  • 7. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L, Cheng J, Chi Q, Qie J, Liu Y, Mei X.
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
    [Abstract] [Full Text] [Related]

  • 8. A new biodegradable copolymer of glycolic acid and lactones with relatively low molecular weight prepared by direct copolycondensation in the absence of catalysts.
    Fukuzaki H, Yoshida M, Asano M, Kumakura M, Mashimo T, Yuasa H, Imai K, Yamanaka H, Kawaharada U, Suzuki K.
    J Biomed Mater Res; 1991 Mar; 25(3):315-28. PubMed ID: 2026638
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of Orntide microspheres in a rat animal model and correlation to in vitro release profiles.
    Kostanski JW, Dani BA, Reynolds GA, Bowers CY, DeLuca PP.
    AAPS PharmSciTech; 2000 Oct 01; 1(4):E27. PubMed ID: 14727892
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanisms involved in the pituitary desensitization induced by gonadotropin-releasing hormone agonists.
    Uemura T, Yanagisawa T, Shirasu K, Matsuyama A, Minaguchi H.
    Am J Obstet Gynecol; 1992 Jul 01; 167(1):283-91. PubMed ID: 1332475
    [Abstract] [Full Text] [Related]

  • 19. Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonists.
    Haviv F, Fitzpatrick TD, Swenson RE, Nichols CJ, Mort NA, Bush EN, Diaz G, Bammert G, Nguyen A, Rhutasel NS.
    J Med Chem; 1993 Feb 05; 36(3):363-9. PubMed ID: 8381183
    [Abstract] [Full Text] [Related]

  • 20. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
    Andreyko JL, Blumenfeld Z, Marshall LA, Monroe SE, Hricak H, Jaffe RB.
    Am J Obstet Gynecol; 1988 Apr 05; 158(4):903-10. PubMed ID: 2966587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.